Santen Pharmaceutical Co Ltd's ticker is SNPHY and the CUSIP is 80287P100. A total of 3 filers reported holding Santen Pharmaceutical Co Ltd in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | – | 76 | +111.1% | 0.00% | – |
| Q1 2022 | $0 | – | 36 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 36 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 36 | -77.4% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 159 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | -33.3% | 159 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $3,000 | 0.0% | 159 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $3,000 | 0.0% | 159 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $3,000 | 0.0% | 159 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $3,000 | 0.0% | 159 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $3,000 | 0.0% | 159 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $3,000 | 0.0% | 159 | -15.9% | 0.00% | 0.0% |
| Q2 2019 | $3,000 | +50.0% | 189 | +18.9% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 159 | -6.5% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 170 | -9.6% | 0.00% | – |
| Q3 2018 | $2,000 | -33.3% | 188 | -0.5% | 0.00% | -100.0% |
| Q2 2018 | $3,000 | -40.0% | 189 | -36.8% | 0.00% | 0.0% |
| Q1 2018 | $5,000 | -37.5% | 299 | -51.1% | 0.00% | -50.0% |
| Q4 2017 | $8,000 | – | 612 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 1,577,090 | $25,659,000 | 0.02% |
| MEEDER ASSET MANAGEMENT INC | 199 | $3,000 | 0.00% |
| Private Capital Group, LLC | 159 | $3,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 625 | $10,000 | 0.00% |